Research and Markets: Ono IMS Company Profile

* Reuters is not responsible for the content in this press release.

Mon May 18, 2009 9:32am EDT

DUBLIN--(Business Wire)--
Research and Markets
(http://www.researchandmarkets.com/research/2bb5b4/ono_ims_company_pr) has
announced the addition of the "Ono IMS Company Profile" company profile to their
offering. 

This Company Profile gives you the authoritative insight into a company at a
strategic and local level. 

Each individual profile analyzes the critical components that make up a
pharmaceutical company, providing you with a clear assessment of the relative
strengths and weaknesses of a company's business strategy.

* Critical analyses provided by an in-house expert team 
* 90+ full in-depth company profiles covering all major pharmaceutical companies
worldwide including private companies 
* Includes some Generic, Biotechnology and Drug Delivery companies 
* Includes sales data on products and therapies 
* In depth product and R&D reviews, including clinical trial, lifecycle
management, competition and analysts forecasts 
* Mergers and acquisitions; licensing agreements 
* Forecasts and comments from leading financial analysts 
* Companies' conferences, annual reports, press releases 
* Comments from stockbrokers/analysts reports used throughout the profile and
especially within the Strategy, Financial and Product sections.

Key Topics Covered:

* Corporate Structure 
* Strategy statement 
* Highlights a company's strengths / weaknesses and its potential for future
growth. The strategy analysis gives you an insight into the following: 
* M&A 
* Financial Review 
* Company sales performance as well as analyst's comments and forecasts. 
* Company Sales Performance: 
* Product Portfolio 
* R&D Pipelines 
* Comprehensive details of the projects that the company has in its R&D pipeline
including: 
* Key figures 
* Analyst figures 
* IMS sales data 
* Employee data 
* Licensing/Co-Marketing Agreements 
* Displayed in a tabular format to enable you to have "at a glance" review of
the licensing activities of the company. 
* Three sections are available to review licensing activities: 
* Major Events 
* Summary of the major events that have affected the company. This includes
recent and historical events.

For more information visit
http://www.researchandmarkets.com/research/2bb5b4/ono_ims_company_pr

Source: IMS Health 





Research and Markets
Laura Wood
Senior Manager
press@researchandmarkets.com
Fax from USA: 646-607-1907
Fax from rest of the world: +353-1-481-1716 

Copyright Business Wire 2009

Comments (0)
This discussion is now closed. We welcome comments on our articles for a limited period after their publication.